Krystal Biotech Inc — Cash Flow (NASDAQ:KRYS) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities 26.08 M47.94 M100.57 M88.8 M123.42 M200.87 M 200.87 M Cash from investing activities 11.18 M226.77 M114.08 M82.64 M163.44 M58.42 M 58.42 M Cash from financing activities 118.02 M347.69 M35.35 M202.75 M27.01 M8.71 M 8.71 M Free cash flow 11.24 M-20.4 M47.59 M77 M119.18 M188.91 M 188.91 M

Notizie

Il direttore di Krystal Biotech Janney vende azioni per 10,1 milioni di dollari

Krystal Biotech director Janney sells shares worth $10.1 million

Il direttore di Krystal Biotech (KRYS) Rossi vende azioni per 4,95 milioni di dollari

Krystal Biotech (KRYS) director Rossi sells shares worth $4.95 million

AI Play SPX Leads 17 Top Performers Onto Best Stock Screens Like IBD 50, Stock Spotlight, More

Krystal Biotech Q4 Earnings Beat Estimates, Revenues Miss Mark

Dow Jones Futures Fall After Market Reverses Higher; Meta Deal Lifts Nvidia, Hits AI Rivals

Krystal Biotech, Inc. (KRYS) Q4 2025 Earnings Call Transcript

Krystal Biotech raggiunge il massimo storico a 296,78 USD

Krystal Biotech stock reaches all-time high at 296.78 USD

Krystal Biotech Q4 2025 slides: VYJUVEK drives revenue growth, pipeline advances

Krystal Biotech shares fall over 2% despite Q4 earnings, revenue beat